Using AI for personalized breast cancer risk assessment: An important tool for early detection

November 29, 2024

Finally, selecting an AI vendor for breast imaging committed to continuous innovation in personalized cancer screening is essential to prevent technological obsolescence. A vendor focused on long-term program success, not just algorithms, ensures you deliver cutting-edge care while fostering a partnership invested in improving patient outcomes.

About the author: Lester Litchfield is the head of data science for Volpara Health, a Lunit company.

Back to HCB News

You don’t have to invest heavily in CT technology to achieve your Coronary CTA goals

Fast-moving cardiac structures have a big impact on imaging. Fujifilm’s SCENARIA View premium performance CT brings solutions to address motion in Coronary CTA while delivering unique dose saving and workflow increasing benefits.



You Must Be Logged In To Post A Comment Entrar Se você já criou uma conta, use seu endereço de e-mail e senha para entrar usando o formulário abaixo. Problemas de login: Estale aqui se você estiver tendo problemas de login. Endereço de email: Senha: Esqueceu sua senha? Problemas de login? Veja nosso Notícia legal e Aviso de privacidade Registo O registro é gratuito e fácil. Aproveite os benefícios dos principais produtos novos e inovadores do mundo. Mercado de equipamentos médicos usados. Registrar agora!